Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.17 -0.04 (-3.28%)
As of: Aug 21, 2026 · 3:28 PM EDT

Phio Pharmaceuticals (PHIO) EBIT Margin Growth (5y) (2017 - 2019)

Phio Pharmaceuticals (PHIO) EBIT Margin Growth (5y) (2017 - 2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.71 Bn 130.86 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.60 Bn 77.60 Bn 3.93 Bn
3 Argenx Se 64.82 Bn 59.63 Bn 1.37 Bn
4 Moderna 57.92 Bn 52.79 Bn 52.00 Mn
5 BeOne Medicines 41.88 Bn 36.78 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.46 Bn 28.15 Bn 992.69 Mn
7 BioNTech SE 27.96 Bn 9.57 Bn 668.28 Mn
8 Insmed 27.35 Bn 26.19 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Phio Pharmaceuticals 13.59 Mn 13.59 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2019 -232,250.00
Sep 30, 2018 -36,646.00
Jun 30, 2018 -240,080.00
Mar 31, 2018 1.74 Mn
Dec 31, 2017 -899,333.00